BHB Therapeutics, Ltd.
Dementia and neurodegenerative conditions are a tremendous burden on our healthcare system and economy.
BHB Therapeutics, Ltd. is a joint partnership between Juvenescence and The Buck Institute for Research on Aging.
The company will focus on novel approaches to inducing a state of ketosis, which may have protective effects against age-related disease. Ketosis is the state where the body burns fat instead of carbohydrates, increasing the production of anti-inflammatory ketone bodies.
The work is based on the research in the labs of Drs.
BHB Therapeutics is part of our continuing commitment to develop and bring products to consumers that have a strong evidence of providing scientific benefit to an aging population.